Loading clinical trials...
Loading clinical trials...
Feasibility of Whole-body MRI for Cancer Surveillance in Children and Young People With Ataxia Telangiectasia
Conditions
Interventions
Magnetic Resonance Imaging and an optional blood test
Locations
1
United Kingdom
University of Nottingham
Nottingham, United Kingdom
Start Date
October 17, 2022
Primary Completion Date
November 30, 2023
Completion Date
November 30, 2023
Last Updated
February 7, 2024
NCT05692596
NCT06664853
NCT04991701
NCT04037189
NCT02285348
Lead Sponsor
University of Nottingham
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions